Neurocrine (NBIX) Company Statistics | The Fly

Search...

/

Dashboard

Charting

KPIs

Stock Screener

ETF Screener

Earnings Calendar

Events Calendar

Syndicate

Street Research

Portfolios

Alert Settings

© 2026 The Fly Inc.

The Fly Cast

Press play to listen

©

Neurocrine (NBIX) Company Statistics | The Fly

Neurocrine

· NBIX

Dashboard

Financials

KPIs

Ratios

Transcripts

Valuation

Statistics

14.063 B

+2.52%

General

Market Cap: $14.06B
Enterprise Value: $14.33B
Shares Outstanding: 100,550,000
Dividend: —
Employees: —
Revenue Per Employee: —

Fundamental Ratios (TTM)

Gross Margin: 97.97%
Operating Margin: 23.38%
Net Profit Margin: 20.91%
FCF Margin: 25.80%
ROA: 13.16%
ROE: 21.13%
ROIC: 13.20%
Current Ratio: 1.87
Debt-to-Equity: 0.11
Revenue Per Employee: —

Valuation (TTM)

P/E: 20.31
PEG: 0.48
P/S: 4.23
P/FCF: 16.39
P/B: 3.86
EV/EBITDA: 15.61

Growth

Rev 1Y: 21.45%

Income Statement (TTM)

Revenue: $3.37B
Gross Margin: 97.97%
Operating Expenses: $2.52B
Operating Income: $788.9M
Net Profit: $705.5M

Balance Sheet

Rev 1Y Fwd Est

36.49%

Rev 3Y (CAGR)

24.32%

Rev 5Y (CAGR)

22.29%

Rev 10Y (CAGR)

64.45%

EPS 1Y

41.95%

EPS 1Y Fwd Est

51.22%

EPS 3Y (CAGR)

44.12%

EPS 5Y (CAGR)

2.34%

EPS 10Y (CAGR)

—

Cash and Equivalents: $332.4M
Working Capital: $763M
Total Assets: $5.36B
Net Debt: $69.4M
Total Liabilities: $1.67B
Total Equity: $3.69B

Cash Flow Statement (TTM)

Cash Flow from Operations: $898.1M
Cash Flow from Investing: -$891.2M
Cash Flow from Financing: $60.2M
Free Cash Flow: $870.4M
Capital Expenditures: $27.7M